| Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case–control study DT Rubin, D Huo, JA Kinnucan, MS Sedrak, NE McCullom, AP Bunnag, ... Clinical gastroenterology and hepatology 11 (12), 1601-1608. e4, 2013 | 391* | 2013 |
| Older adult participation in cancer clinical trials: a systematic review of barriers and interventions MS Sedrak, RA Freedman, HJ Cohen, HB Muss, A Jatoi, HD Klepin, ... CA: a cancer journal for clinicians 71 (1), 78-92, 2021 | 295 | 2021 |
| Geriatric assessment–driven intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial D Li, CL Sun, H Kim, E Soto-Perez-de-Celis, V Chung, M Koczywas, ... JAMA oncology 7 (11), e214158-e214158, 2021 | 253 | 2021 |
| Geriatric assessment-driven intervention (GAIN) on chemotherapy toxicity in older adults with cancer: A randomized controlled trial. D Li, CL Sun, H Kim, V Chung, M Koczywas, M Fakih, J Chao, L Chien, ... Journal of Clinical Oncology 38 (15_suppl), 12010-12010, 2020 | 104 | 2020 |
| Residents' self‐report on why they order perceived unnecessary inpatient laboratory tests MS Sedrak, MS Patel, JB Ziemba, D Murray, EJ Kim, CJ Dine, JS Myers Journal of hospital medicine 11 (12), 869-872, 2016 | 102 | 2016 |
| NCCN guidelines® insights: older adult oncology, version 1.2021: featured updates to the NCCN guidelines E Dotan, LC Walter, IS Browner, K Clifton, HJ Cohen, M Extermann, ... Journal of the National Comprehensive Cancer Network 19 (9), 1006-1019, 2021 | 97 | 2021 |
| Cancer communication in the social media age MS Sedrak, RB Cohen, RM Merchant, MM Schapira JAMA oncology 2 (6), 822-823, 2016 | 80 | 2016 |
| Development and validation of a risk tool for predicting severe toxicity in older adults receiving chemotherapy for early-stage breast cancer A Magnuson, MS Sedrak, CP Gross, WP Tew, HD Klepin, TM Wildes, ... Journal of Clinical Oncology 39 (6), 608, 2021 | 79 | 2021 |
| Effect of a price transparency intervention in the electronic health record on clinician ordering of inpatient laboratory tests: the PRICE randomized clinical trial MS Sedrak, JS Myers, DS Small, I Nachamkin, JB Ziemba, D Murray, ... JAMA internal medicine 177 (7), 939-945, 2017 | 74 | 2017 |
| Barriers to clinical trial enrollment of older adults with cancer: A qualitative study of the perceptions of community and academic oncologists MS Sedrak, SG Mohile, V Sun, CL Sun, BT Chen, D Li, AR Wong, ... Journal of geriatric oncology 11 (2), 327-334, 2020 | 59 | 2020 |
| A phase II clinical trial of pembrolizumab and enobosarm in patients with androgen receptor‐positive metastatic triple‐negative breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... The oncologist 26 (2), 99-e217, 2021 | 58 | 2021 |
| Use of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors in older patients with ER-positive HER2-negative breast cancer: Young International Society of Geriatric Oncology review … NML Battisti, N De Glas, MS Sedrak, KP Loh, G Liposits, ... Therapeutic Advances in Medical Oncology 10, 1758835918809610, 2018 | 51 | 2018 |
| Social media in cancer care: highlights, challenges & opportunities DJ Attai, MS Sedrak, MS Katz, MA Thompson, PF Anderson, ... Future oncology 12 (13), 1549-1552, 2016 | 51 | 2016 |
| Barriers to participation in therapeutic clinical trials as perceived by community oncologists AR Wong, V Sun, K George, J Liu, S Padam, BA Chen, T George, A Amini, ... JCO oncology practice 16 (9), e849-e858, 2020 | 44 | 2020 |
| Online health information–seeking among older women with chronic illness: analysis of the women’s health initiative MS Sedrak, E Soto-Perez-De-Celis, RA Nelson, J Liu, ME Waring, ... Journal of medical Internet research 22 (4), e15906, 2020 | 44 | 2020 |
| Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer Y Yuan, JS Lee, SE Yost, PH Frankel, C Ruel, CA Egelston, W Guo, ... European Journal of Cancer 154, 11-20, 2021 | 43 | 2021 |
| The emerging role of professional social media use in oncology MS Sedrak, DS Dizon, PF Anderson, MJ Fisch, DL Graham, MS Katz, ... Future oncology 13 (15), 1281-1285, 2017 | 39 | 2017 |
| Risks and benefits of Twitter use by hematologists/oncologists in the era of digital medicine DJ Attai, PF Anderson, MJ Fisch, DL Graham, MS Katz, J Kesselheim, ... Seminars in hematology 54 (4), 198-204, 2017 | 35 | 2017 |
| Arti Hurria and the progress in integrating the geriatric assessment into oncology: Young International Society of Geriatric Oncology review paper C DuMontier, MS Sedrak, WK Soo, C Kenis, GR Williams, K Haase, ... Journal of geriatric oncology 11 (2), 203-211, 2020 | 34 | 2020 |
| Geriatric Assessment-Driven Intervention (GAIN) on chemotherapy-related toxic effects in older adults with cancer: a randomized clinical trial. JAMA Oncol. 2021; 7 (11): e214158 D Li, CL Sun, H Kim, E Soto-Perez-de-Celis, V Chung, M Koczywas, ... DOI: https://doi. org/10.1001/jamaoncol, 2021 | 32 | 2021 |
